KymaThera

Series-B+
kymathera.com Biotech & Healthcare San Diego, United States 1-10
Total Funding $80M
Latest Round $80M Series-B+
Last Announced Oct 6, 2026
Investors 4 Backers
Decision Makers Profile Active

About KymaThera

Develops K-1728, a therapy for HR-positive, HER2-negative breast cancer.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters San Diego, United States
Team Size 1-10
Tracked Since Oct 7, 2026

Web & Domain Identity

Official Website kymathera.com
Domain Registered Date Dec 18, 2023

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $80,000,000 · Series-B

    Backed by Alta Partners

  2. Milestone

    Website domain registered

    kymathera.com

Investors & Backers

4
Alta Partners
Foresite Capital
J. Wood Capital Advisors
Venrock

Funding History

1 Round
Series-B equity · Oct 6, 2026

Round backers: Alta Partners

$80,000,000 citybiz.co

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts